- Home
- CCRN vs LXEO Comparison
CCRN vs LXEO Comparison
Compare CCRN & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCRN | LXEO |
|---|---|---|
| Founded | 1986 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.7M | 396.5M |
| IPO Year | 2001 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CCRN | LXEO |
|---|---|---|
| Price | $13.26 | $4.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $14.15 | ★ $18.44 |
| AVG Volume (30 Days) | 561.2K | ★ 962.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.81 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $816,484,000.00 | $654,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.43 | $3.60 |
| 52 Week High | $14.98 | $10.99 |
Technical Indicators
Market Signals| Indicator | CCRN | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 74.80 | 45.39 |
| Support Level | $13.02 | $4.27 |
| Resistance Level | $13.45 | $5.36 |
| Average True Range (ATR) | 0.02 | 0.35 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 81.25 | 22.86 |
Price Performance
Historical ComparisonAbout CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.